surmount 1 tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in -1 Study I wouldn't call 23% a
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Live Spec
I wouldn't call 23% a miss. SURMOUNT 1 data reminds us that tirzepatide did not work for weight loss in ~10% of people. All of my patients who didn't see significant #weightloss with SURMOUNT 1 Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT 2): a double blind, randomised, multicentre, placebo controlled, phase 3 trial The Lancet SURMOUNT 1 Trial Cardionerds Twitter Journal Club Gastrointestinal tolerability and weight reduction associated with tirzepatide in adults with obesity or overweight with and without type 2 diabetes in the SURMOUNT1 to 4 trials Rubino 2025 Diabetes
Store: capewinelands.gov.za · Domain: capewinelands.gov.za

























